Area of Interest under PHO ISO: ASCENT-IBO

HEALTH AND HUMAN SERVICES, DEPARTMENT OF — NATIONAL INSTITUTES OF HEAL·DC*·Other·Federal

Scope

See attached Special Notice ARPA-H-SN-26-158: Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO) This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers� Day event.

Documents, amendments and submission instructions are on the agency's own posting.